Telo Genomics Corporation (QB) (TDSGF)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current TDSGF market cap is 10.2M. The company's latest EPS is CAD -0.0271 and P/E is -5.17.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.31M | -1.26M | -2.11M | -2.82M | -2.72M |
| Net Income | -1.24M | -1.07M | -2.11M | -2.82M | -2.71M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.17M | 3.84M | 2.83M | 2.93M | 965k |
| Total Liabilities | 393k | 154k | 230k | 313k | 375k |
| Total Equity | 775k | 3.69M | 2.6M | 2.61M | 590k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.12M | -1.11M | -1.8M | -2.63M | -2.46M |
| Investing | -8k | -9k | -25k | -69k | -5k |
| Financing | 2.03M | 3.83M | 876k | 2.68M | 587k |
| Market Cap | 10.2M |
| Price to Earnings Ratio | -5.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 17.5 |
| Price to Book Ratio | 23.73 |
| Dividend Yield | - |
| Shares Outstanding | 100.02M |
| Average Volume (1 week) | 1,000 |
| Average Volume (1 Month) | 25.58k |
| 52 Week Change | -15.14% |
| 52 Week High | 0.1793 |
| 52 Week Low | 0.0683 |
| Spread (Intraday) | 0.03 (22.55%) |
| Company Name | Telo Genomics Corporation (QB) |
| Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
| Website | https://www.telodx.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
